Stereotaxis to Report Fourth Quarter and Full Year 2022 Financial Results on March 3, 2023 - Yahoo Finance
| OZSC Stock | USD 0.0006 0.0001 14.29% |
About 61% of Ozop Surgical's investor base is looking to short. The analysis of overall sentiment of trading Ozop Surgical Corp pink sheet suggests that many investors are alarmed at this time. The current market sentiment, together with Ozop Surgical's historical and current headlines, can help investors time the market. In addition, many technical investors use Ozop Surgical Corp stock news signals to limit their universe of possible portfolio assets.
Ozop |
Stereotaxis to Report Fourth Quarter and Full Year 2022 Financial Results on March 3, 2023 Yahoo Finance
Read at news.google.com
 |
Ozop Surgical Fundamental Analysis
We analyze Ozop Surgical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Ozop Surgical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Ozop Surgical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Price To Sales
Price To Sales Comparative Analysis
Ozop Surgical is currently under evaluation in price to sales category among its peers. Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Ozop Surgical Corp Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Ozop Surgical pink sheet to make a market-neutral strategy. Peer analysis of Ozop Surgical could also be used in its relative valuation, which is a method of valuing Ozop Surgical by comparing valuation metrics with similar companies.
Peers
Ozop Surgical Related Equities
| EOSEW | Eos Energy | 61.43 | ||||
| LGRDY | Legrand SA | 0.21 | ||||
| NVX | Novonix | 0.00 |
Complementary Tools for Ozop Pink Sheet analysis
When running Ozop Surgical's price analysis, check to measure Ozop Surgical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ozop Surgical is operating at the current time. Most of Ozop Surgical's value examination focuses on studying past and present price action to predict the probability of Ozop Surgical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ozop Surgical's price. Additionally, you may evaluate how the addition of Ozop Surgical to your portfolios can decrease your overall portfolio volatility.
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |